These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 18951446)

  • 1. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
    Plon SE; Eccles DM; Easton D; Foulkes WD; Genuardi M; Greenblatt MS; Hogervorst FB; Hoogerbrugge N; Spurdle AB; Tavtigian SV;
    Hum Mutat; 2008 Nov; 29(11):1282-91. PubMed ID: 18951446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
    Tavtigian SV; Greenblatt MS; Goldgar DE; Boffetta P;
    Hum Mutat; 2008 Nov; 29(11):1261-4. PubMed ID: 18951436
    [No Abstract]   [Full Text] [Related]  

  • 3. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
    Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB;
    Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.
    Greenblatt MS; Brody LC; Foulkes WD; Genuardi M; Hofstra RM; Olivier M; Plon SE; Sijmons RH; Sinilnikova O; Spurdle AB;
    Hum Mutat; 2008 Nov; 29(11):1273-81. PubMed ID: 18951438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium.
    Janatová M; Chvojka Š; Macháčková E; Soukupová J; Zemánková P; Nehasil P; Zavoral T; Hrušková L; Janíková KMK; Lhota F; Tavandzis S; Kleiblová P; Kleibl Z; Konzorcium C
    Klin Onkol; 2023; 37(6):431-439. PubMed ID: 38158231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of missense substitutions using sequence-alignment based methods.
    Tavtigian SV; Greenblatt MS; Lesueur F; Byrnes GB;
    Hum Mutat; 2008 Nov; 29(11):1327-36. PubMed ID: 18951440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of functional effects of unclassified genetic variants.
    Couch FJ; Rasmussen LJ; Hofstra R; Monteiro AN; Greenblatt MS; de Wind N;
    Hum Mutat; 2008 Nov; 29(11):1314-26. PubMed ID: 18951449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
    Macklin S; Durand N; Atwal P; Hines S
    Genet Med; 2018 Mar; 20(3):346-350. PubMed ID: 29215655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care.
    Chiang J; Chia TH; Yuen J; Shaw T; Li ST; Binte Ishak ND; Chew EL; Chong ST; Chan SH; Ngeow J
    JCO Precis Oncol; 2021 Nov; 5():577-584. PubMed ID: 34994607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
    Lincoln SE; Kobayashi Y; Anderson MJ; Yang S; Desmond AJ; Mills MA; Nilsen GB; Jacobs KB; Monzon FA; Kurian AW; Ford JM; Ellisen LW
    J Mol Diagn; 2015 Sep; 17(5):533-44. PubMed ID: 26207792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic diagnosis of cancers? Which cancers should be screened?].
    Chompret A
    Ann Med Interne (Paris); 2001 Jun; 152(4):249-61. PubMed ID: 11474373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience.
    Bland A; Harrington EA; Dunn K; Pariani M; Platt JCK; Grove ME; Caleshu C
    Genet Med; 2018 Mar; 20(3):369-373. PubMed ID: 29240077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.
    Rosenthal ET; Bowles KR; Pruss D; van Kan A; Vail PJ; McElroy H; Wenstrup RJ
    Clin Genet; 2015 Dec; 88(6):533-41. PubMed ID: 25639900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    King E; Mahon SM
    Clin J Oncol Nurs; 2017 Oct; 21(5):589-598. PubMed ID: 28945723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Inherited Variants to Hereditary Cancer Syndrome Predisposition.
    Güleç Ceylan G; Arslan Satılmış SB; Çavdarlı B; Semerci Gündüz CN
    Tohoku J Exp Med; 2022 Nov; 258(4):319-325. PubMed ID: 36288950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.
    Karam R; Conner B; LaDuca H; McGoldrick K; Krempely K; Richardson ME; Zimmermann H; Gutierrez S; Reineke P; Hoang L; Allen K; Yussuf A; Farber-Katz S; Rana HQ; Culver S; Lee J; Nashed S; Toppmeyer D; Collins D; Haynes G; Pesaran T; Dolinsky JS; Tippin Davis B; Elliott A; Chao E
    JAMA Netw Open; 2019 Oct; 2(10):e1913900. PubMed ID: 31642931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.
    Mitchell SG; Pencheva B; Porter CC
    Curr Oncol Rep; 2019 Aug; 21(10):85. PubMed ID: 31414239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.